Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
TransMedics Reports Positive Data From OCS DCD Heart Trial
TransMedics Group Inc (NASDAQ: TMDX) has announced topline results from its OCS donors after circulatory death (DCD) Heart Trial.
TransMedics’ OCS Heart System Scores FDA Approval
TransMedics Group Inc (NASDAQ:TMDX) has received FDA premarket approval (PMA) for its OCS Heart system. Related content: Benzinga’s Full FDA Calendar. TransMedics designed…
Looking into TransMedics Group’s Return on Capital Employed
Pulled from Benzinga Pro data TransMedics Group (NASDAQ:TMDX) reported Q2 sales of $8.17 million. Earnings fell to a loss of $9.87 million, resulting in a 51.65% decrease from last quarter.
TransMedics Group Q2 EPS $(0.39) Misses $(0.28) Estimate, Sales $8.17M Beat $7.80M Estimate
TransMedics Group (NASDAQ:TMDX) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.28) by 39.29 percent. This is a 8.33 percent decrease over losses of $(0.36) per share
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
TransMedics Late Yesterday Announces Co Has Received FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs
TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced